Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13
Latest In: Hemp & CBD
Raphael Mechoulam, ‘father of cannabis research,’ dies at 92
Hebrew University Professor Raphael Mechoulam, considered the “father of cannabis research,” has died in Israel.
News March 10
Restrictions on delta-8 THC products advance in Kentucky
Delta-8 THC products sold in Kentucky would be restricted to buyers 21 and older and would have to…
News March 10
Virginia medical groups urge gov to sign delta-8 THC bill
Medical groups in Virginia are asking the governor to sign a bill as written that adds new restrictions to…
News March 10
THC-containing hemp products become political issue in Louisiana
The Republican speaker of Louisiana's House of Representatives is displeased with the state health department because hemp-derived products…
News March 9
Virginia cannabis advocates push for changes to approved delta-8 bill
The Virginia Cannabis Association (VCA) wants the state's recently passed delta-8 THC bill to be amended because it…
News March 7
Bids stall to restrict high-THC products in Washington state
Efforts to cap the potency of cannabis products in Washington state and limit high-potency THC to the medical…
News March 3
Virginia lawmakers pass tough delta-8 THC restrictions
Virginia lawmakers approved tough new restrictions on products containing the controversial hemp-derived cannabinoid delta-8 THC.
News February 28
Synthetic cannabinoid maker Nalu Bio raises $12 million
Nalu Bio, a producer of synthetic cannabinoids, said it raised $12 million in a Series A funding round…
News February 28
Virginia’s adult-use cannabis market stalled indefinitely
Less than two years after Virginia became the first in the South to legalize adult-use marijuana, the projected…
News February 27
Latest Sponsored
